LAURENCE DOYLE

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Telomerase as a diagnostic and therapeutic target for cancer
    L Austin Doyle
    Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD 21201, USA
    Expert Rev Anticancer Ther 2:217-25. 2002
  2. ncbi Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
    L Austin Doyle
    The University of Maryland Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD 21201, USA
    Oncogene 22:7340-58. 2003

Collaborators

Detail Information

Publications2

  1. ncbi Telomerase as a diagnostic and therapeutic target for cancer
    L Austin Doyle
    Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD 21201, USA
    Expert Rev Anticancer Ther 2:217-25. 2002
    ..Due to its widespread occurrence in cancer and its crucial role in the maintenance of the tumor, telomerase is an attractive target for cancer diagnosis and treatment...
  2. ncbi Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
    L Austin Doyle
    The University of Maryland Greenebaum Cancer Center, 22 South Greene Street, Baltimore, MD 21201, USA
    Oncogene 22:7340-58. 2003
    ..More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional assays, in order to determine the contribution of BCRP to drug resistance in human cancers...